Language

Maropitant Citrate CAS：359875-09-5

NAME:Maropitant Citrate CAS：359875-09-5 MF:C38H50N2O9 MW: 678.82 Purity:98%min Appearance:white powder COA:Provide Sample:Negotiable

Categories：

Life Science Chemicals

Pharmaceutical Intermediates

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

PRODUCT NAME	Maropitant Citrate
CAS NO	359875-09-5
MP	153-159 °C(lit.)
FP	100 °C
EINECS	201-069-1
STORAGE	2-8°C
DELIVERY	2-3DAYS
PACKAGE	According client's request

Description of Maropitant Citrate CAS：359875-09-5

Maropitant citrate, developed by Zoetis, is a neurokinin receptor antagonist used specifically for the treatment of motion sickness and vomiting in dogs . It was approved by the FDA in 2007 for use in dogs and more recently has also been approved for use in cats.

Applications of Maropitant Citrate CAS：359875-09-5

1)Pharmacokinetics in Avian Species : Maropitant citrate has been studied in birds like Rhode Island Red chickens, providing essential pharmacokinetic data for avian species. These studies help in understanding dosing and frequency for effective use in birds

2)Visceral Analgesia in Dogs and Cats : Investigations have shown that maropitant citrate could be an alternative for treating visceral pain in dogs and cats. It reduces the minimum alveolar concentration of anesthetic agents, indicating potential use in anesthetic protocols

3)Applications in Horses : Studies have been conducted to understand the pharmacokinetics of maropitant citrate in horses after intravenous and intragastric doses. This research lays the groundwork for potential therapeutic uses of maropitant in equine medicine

4)Use in Rabbits : Research has also focused on the pharmacokinetics and adverse effects of maropitant citrate in New Zealand White rabbits, further broadening the scope of its veterinary applications

5)Anti-inflammatory and Analgesic Properties : A systematic review and meta-analysis evaluated the anti-inflammatory, analgesic, and anesthesia-sparing effects of maropitant.

Key words: